Published: 26. May, 2020
Novel painkiller is remarkably close to market, and the team is now expanding its business development activities
Novel painkiller needs backing to reach kids in pain
When a doctor faces a child in pain, she has very few remedies to comfort her patient. None of them ideal. Now, a team from the Copenhagen Science City-partner University Hospital Rigshospitalet has developed a simple way to provide rapid pain-relief to young patients. Though still in development, it is remarkably close to market. It will take just three years and 50 million DKK to secure a permission to sell the novel pain treatment for children, so now the team is looking for investors.
Novel painkiller needs backing to reach kids in pain
